APA (7th ed.) Citation

Lobo, E. D., Heathman, M., Kuan, H., Reddy, S., O’Brien, L., Gonzales, C., . . . Knadler, M. P. (2010). Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials. Clinical pharmacokinetics, 49(5), 311-321. https://doi.org/10.2165/11319330-000000000-00000

Chicago Style (17th ed.) Citation

Lobo, Evelyn D., Michael Heathman, Han-Yi Kuan, Shobha Reddy, Lisa O’Brien, Celedon Gonzales, Michael Skinner, and Mary Pat Knadler. "Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials." Clinical Pharmacokinetics 49, no. 5 (2010): 311-321. https://doi.org/10.2165/11319330-000000000-00000.

MLA (9th ed.) Citation

Lobo, Evelyn D., et al. "Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials." Clinical Pharmacokinetics, vol. 49, no. 5, 2010, pp. 311-321, https://doi.org/10.2165/11319330-000000000-00000.